4
Changes in Ownership
BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-22-005295
Director sold 5,000 shares at $18.50 ($92,500)
- Director acquired 5,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| ABERCROMBIE GEORGE B Director | 2022-02-15 | Option exercise | +5,000 | $3.32 | $16,600 | 5,000 | D |
| ABERCROMBIE GEORGE B Director | 2022-02-15 | Sale | −5,000 | $18.50 | $92,500 | 0 | D |
| Derivatives | |||||||
| ABERCROMBIE GEORGE B Director | 2022-02-15 | Option exercise · Automatic Stock Option Grant | −5,000 | 5,000 | D | ||
| Open-market sales · 5,000 sh · avg $18.50 · $92,500 | |||||||
Loading xslF345X03/form4.xml…